Results 251 to 260 of about 237,695 (301)
Comparison of the conditional approvals for anticancer drugs supported by single-arm trials in China and the United States: clinical evidence, post-marketing requirements, and regulatory outcomes. [PDF]
Du Y, Zhang S, Yang L.
europepmc +1 more source
Conditional Value-at-Risk and Average Value-at-Risk: Estimation and Asymptotics [PDF]
We discuss linear regression approaches to the estimation of law-invariant conditional risk measures. Two estimation procedures are considered and compared; one is based on residual analysis of the standard least-squares method, and the other is in the spirit of the M-estimation approach used in robust statistics.
So Yeon Chun +2 more
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Distributionally robust reinsurance with Value-at-Risk and Conditional Value-at-Risk
Insurance: Mathematics and Economics, 2021zbMATH Open Web Interface contents unavailable due to conflicting licenses.
Liu, Haiyan, Mao, Tiantian
openaire +1 more source

